CollPlant Biotechnologies Ltd.
CLGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $34,223 | $16,104 | $29,553 | $41,236 |
| - Cash | $8,547 | $11,707 | $10,735 | $11,909 |
| + Debt | $2,940 | $3,027 | $2,843 | $3,081 |
| Enterprise Value | $28,616 | $7,424 | $21,661 | $32,408 |
| Revenue | $77 | $179 | $2,055 | $164 |
| % Growth | -57% | -91.3% | 1,153% | – |
| Gross Profit | -$415 | -$236 | $1,623 | -$350 |
| % Margin | -539% | -131.8% | 79% | -213.4% |
| EBITDA | -$3,260 | -$2,949 | -$1,208 | -$3,636 |
| % Margin | -4,233.8% | -1,647.5% | -58.8% | -2,217.1% |
| Net Income | -$3,483 | -$3,347 | -$1,452 | -$3,878 |
| % Margin | -4,523.4% | -1,869.8% | -70.7% | -2,364.6% |
| EPS Diluted | -0.27 | -0.28 | -0.13 | -0.34 |
| % Growth | 3.6% | -115.4% | 61.8% | – |
| Operating Cash Flow | -$2,877 | -$2,440 | -$1,167 | -$3,464 |
| Capital Expenditures | -$1 | -$3 | -$9 | -$59 |
| Free Cash Flow | -$2,878 | -$2,443 | -$1,176 | -$3,523 |